| Citation: |
WANG Lifei, LUO Longlong, ZHENG Ying, LU Lixia, LI Bin, WANG Junke, LI Chuyi, YU Xiaohui, ZHANG Jiucong. Research progress on macrophage migration inhibitory factor in hepatocellular carcinoma[J]. Journal of Clinical Medicine in Practice, 2023, 27(14): 126-130. DOI: 10.7619/jcmp.20231220
|
Macrophage migration inhibitory factor (MIF) is an important cytokine with dual pro-inflammatory and pro-carcinogenic roles. Aberrant expression of MIF can mediate abnormal activation of multiple signaling pathways and cause the occurrence of hepatocellular carcinoma (HCC), and its mechanisms involve processes such as cell proliferation and migration, regulation of apoptosis and autophagy, and neovascularization. Currently, the clinical treatments for patients with advanced HCC mainly rely on interventional therapy and multi-targeted molecular drugs, but the efficacy is relatively limited. Therefore, finding new therapeutic targets and developing novel anti-HCC drugs are the hot topics in the field of liver cancer treatment currently. This paper reviewed the specific mechanisms on occurrence and malignant progression of MIF-induced HCC as well as its potential as a therapeutic target for HCC, with the aim of providing references for the treatment of HCC.
| [1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
|
| [2] |
CAO W, CHEN H D, YU Y W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J, 2021, 134(7): 783-791. doi: 10.1097/CM9.0000000000001474
|
| [3] |
SAYINER M, GOLABI P, YOUNOSSI Z M. Disease burden of hepatocellular carcinoma: a global perspective[J]. Dig Dis Sci, 2019, 64(4): 910-917. doi: 10.1007/s10620-019-05537-2
|
| [4] |
LIN S, SHENG Q W, MA X B, et al. Marsdenia tenacissima extract induces autophagy and apoptosis of hepatocellular cells via MIF/mToR signaling[J]. Evid Based Complement Alternat Med, 2022, 2022: 7354700.
|
| [5] |
RONOT M, BOUATTOUR M, WASSERMANN J, et al. Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors[RECIST]) Versus RECIST 1. 1 in patients with advanced hepatocellular carcinoma treated with sorafenib[J]. Oncologist, 2014, 19(4): 394-402. doi: 10.1634/theoncologist.2013-0114
|
| [6] |
VOGEL A, MEYER T, SAPISOCHIN G, et al. Hepatocellular carcinoma[J]. Lancet, 2022, 400(10360): 1345-1362. doi: 10.1016/S0140-6736(22)01200-4
|
| [7] |
BLOOM B R, BENNETT B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity[J]. Science, 1966, 153(3731): 80-82. doi: 10.1126/science.153.3731.80
|
| [8] |
O'REILLY C, DOROUDIAN M, MAWHINNEY L, et al. Targeting MIF in cancer: therapeutic strategies, current developments, and future opportunities[J]. Med Res Rev, 2016, 36(3): 440-460. doi: 10.1002/med.21385
|
| [9] |
HEINRICHS D, KNAUEL M, OFFERMANNS C, et al. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74[J]. Proc Natl Acad Sci U S A, 2011, 108(42): 17444-17449. doi: 10.1073/pnas.1107023108
|
| [10] |
WIRTZ T H, FISCHER P, BACKHAUS C, et al. Genetic variants in the promoter region of the macrophage migration inhibitory factor are associated with the severity of hepatitis C virus-induced liver fibrosis[J]. Int J Mol Sci, 2019, 20(15): 3753. doi: 10.3390/ijms20153753
|
| [11] |
BARNES M A, MCMULLEN M R, ROYCHOWDHURY S, et al. Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis[J]. Hepatology, 2013, 57(5): 1980-1991. doi: 10.1002/hep.26169
|
| [12] |
ZHOU J, YU L, GAO X, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma[J]. J Clin Oncol, 2011, 29(36): 4781-4788. doi: 10.1200/JCO.2011.38.2697
|
| [13] |
WANG D, LUO L, CHEN W, et al. Significance of the vascular endothelial growth factor and the macrophage migration inhibitory factor in the progression of hepatocellular carcinoma[J]. Oncol Rep, 2014, 31(3): 1199-1204. doi: 10.3892/or.2013.2946
|
| [14] |
TRIVEDI-PARMAR V, JORGENSEN W L. Advances and insights for small molecule inhibition of macrophage migration inhibitory factor[J]. J Med Chem, 2018, 61(18): 8104-8119. doi: 10.1021/acs.jmedchem.8b00589
|
| [15] |
SPARKES A, BAETSELIER P D, ROELANTS K, et al. The non-mammalian MIF superfamily[J]. Immunobiology, 2017, 222(3): 473-482. doi: 10.1016/j.imbio.2016.10.006
|
| [16] |
JANKAUSKAS S S, WONG D W L, BUCALA R, et al. Evolving complexity of MIF signaling[J]. Cell Signal, 2019, 57: 76-88. doi: 10.1016/j.cellsig.2019.01.006
|
| [17] |
CALANDRA T, ROGER T. Macrophage migration inhibitory factor: a regulator of innate immunity[J]. Nat Rev Immunol, 2003, 3(10): 791-800. doi: 10.1038/nri1200
|
| [18] |
KOH H M, KIM D C. Prognostic significance of macrophage migration inhibitory factor expression in cancer patients: a systematic review and meta-analysis[J]. Medicine, 2020, 99(32): e21575. doi: 10.1097/MD.0000000000021575
|
| [19] |
JÄGER B, KLATT D, PLAPPERT L, et al. CXCR4/MIF axis amplifies tumor growth and epithelial-mesenchymal interaction in non-small cell lung cancer[J]. Cell Signal, 2020, 73: 109672. doi: 10.1016/j.cellsig.2020.109672
|
| [20] |
PENTICUFF J C, WOOLBRIGHT B L, SIELECKI T M, et al. MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential[J]. Nat Rev Urol, 2019, 16(5): 318-328. doi: 10.1038/s41585-019-0171-9
|
| [21] |
HUANG G, MA L L, SHEN L, et al. MIF/SCL3A2 depletion inhibits the proliferation and metastasis of colorectal cancer cells via the AKT/GSK-3β pathway and cell iron death[J]. J Cell Mol Med, 2022, 26(12): 3410-3422. doi: 10.1111/jcmm.17352
|
| [22] |
SUMAIYA K, LANGFORD D, NATARAJASEENIVASAN K, et al. Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies[J]. Pharmacol Ther, 2022, 233: 108024. doi: 10.1016/j.pharmthera.2021.108024
|
| [23] |
WEN Y J, CAI W H, YANG J Y, et al. Targeting macrophage migration inhibitory factor in acute pancreatitis and pancreatic cancer[J]. Front Pharmacol, 2021, 12: 638950. doi: 10.3389/fphar.2021.638950
|
| [24] |
BOZZI F, MOGAVERO A, VARINELLI L, et al. MIF/CD74 axis is a target for novel therapies in colon carcinomatosis[J]. J Exp Clin Cancer Res, 2017, 36(1): 16. doi: 10.1186/s13046-016-0475-z
|
| [25] |
WIRTZ T H, SAAL A, BERGMANN I, et al. Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma[J]. Br J Pharmacol, 2021, 178(22): 4452-4467. doi: 10.1111/bph.15622
|
| [26] |
纪世博, 庄立伟, 张雨, 等. 巨噬细胞游走抑制因子在乙型肝炎病毒相关性肝细胞癌中的调控作用[J]. 中华实验和临床感染病杂志: 电子版, 2021, 15(6): 379-384. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSGR202106004.htm
|
| [27] |
许羚雁, 黄子京, 刘玉波, 等. 巨噬细胞迁移抑制因子介导缺氧诱导的保护性自噬对肝癌细胞化疗敏感性的影响及机制研究[J]. 中国免疫学杂志, 2022, 38(23): 2886-2890. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ202223012.htm
|
| [28] |
ZHANG Y Y, ZHANG Y, TANG J Y, et al. Oxymatrine inhibits homocysteine-mediated autophagy via MIF/mTOR signaling in human umbilical vein endothelial cells[J]. Cell Physiol Biochem, 2018, 45(5): 1893-1903. doi: 10.1159/000487912
|
| [29] |
梁辉. MIF蛋白、EMT标记蛋白在肝癌组织中的表达及与临床病理特征、预后的相关性[J]. 中国医学创新, 2021, 18(29): 1-6. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCX202129003.htm
|
| [30] |
YU H P, ZHENG Y, LU L X, et al. Preliminary study on the expression of MIF in HCC tissues and its relationship with ERK1/2 signaling pathway[J]. Zhonghua Nei Ke Za Zhi, 2022, 61(11): 1228-1233.
|
| [31] |
魏敏, 曹莉婷, 卢利霞, 等. MIF与JNK1在原发性肝细胞癌中的表达及相关性研究[J]. 胃肠病学和肝病学杂志, 2020, 29(6): 641-646. https://www.cnki.com.cn/Article/CJFDTOTAL-WCBX202006009.htm
|
| [32] |
ILLESCAS O, GOMEZ-VERJAN J C, GARCÍA-VELÁZQUEZ L, et al. Macrophage migration inhibitory factor-173 G/C polymorphism: a global meta-analysis across the disease spectrum[J]. Front Genet, 2018, 9: 55. doi: 10.3389/fgene.2018.00055
|
| [33] |
QIN L F, QIN J M, LV X P, et al. MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma[J]. Oncol Lett, 2021, 22(1): 549. doi: 10.3892/ol.2021.12810
|
| [34] |
WIRTZ T H, LOOSEN S H, SCHULZE-HAGEN M, et al. Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies[J]. Clin Transl Sci, 2021, 14(5): 1853-1863. doi: 10.1111/cts.13033
|
| [35] |
WIRTZ T H, REUKEN P A, JANSEN C, et al. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis[J]. JHEP Rep, 2021, 3(2): 100221. doi: 10.1016/j.jhepr.2020.100221
|
| [36] |
胡迎超. 血清甲胎蛋白和巨噬细胞移动抑制因子水平与原发性肝癌肝动脉化疗栓塞术患者预后的关系[J]. 慢性病学杂志, 2023, 24(1): 116-118. https://www.cnki.com.cn/Article/CJFDTOTAL-YYSO202301032.htm
|
| [37] |
KAMEL M M, SAAD M F, MAHMOUD A A, et al. Evaluation of serum PIVKA-Ⅱ and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinoma[J]. Microb Pathog, 2014, 77: 31-35. doi: 10.1016/j.micpath.2014.10.009
|
| [38] |
ISMAIL M M, MORSI H K, ABDULATEEF N A, et al. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance[J]. Scand J Clin Lab Invest, 2017, 77(3): 175-183. doi: 10.1080/00365513.2017.1286684
|
| [39] |
ZHAO J L, LI H C, ZHAO S J, et al. Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling[J]. Mol Cancer, 2021, 20(1): 46.
|
| [40] |
董辉, 王晶, 杨艳娟, 等. 过表达miR-451a通过靶向巨噬细胞迁移抑制因子(MIF)抑制HepG2细胞的增殖[J]. 细胞与分子免疫学杂志, 2018, 34(12): 1091-1098. https://www.cnki.com.cn/Article/CJFDTOTAL-XBFM201812009.htm
|
| [41] |
WANG K J, LIANG Q, WEI L, et al. microRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor[J]. Tumour Biol, 2016, 37(3): 3823-3830.
|
| [1] | SHU Changxin, WEI Chen, TANG Dong. Role of mitochondrial autophagy-related genes in colorectal cancer based on spatial transcriptomics and single-cell sequencing analysis[J]. Journal of Clinical Medicine in Practice, 2025, 29(7): 92-99. DOI: 10.7619/jcmp.20246396 |
| [2] | JIANG Meini, LIANG Jifang, WANG Xiuzhe, ZHAO Caixia, WU Weidong. Value of neutrophil gelatinase-related lipocalin and autophagy-related protein in evaluating prognosis of elderly patients with sepsis[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 67-71, 77. DOI: 10.7619/jcmp.20220654 |
| [3] | CAO Juan, WANG Hongyi, WANG Lixin, CHEN Xiaoning, LIN Qiu, YANG Qinghong, CHEN Dongzhui, FU Yuxiu. Effects of electroacupuncture on hippocampal neuron autophagy and IGF-1/PI3K/Akt pathway in rats with hypoxic-ischemic brain damage[J]. Journal of Clinical Medicine in Practice, 2022, 26(14): 38-45. DOI: 10.7619/jcmp.20214746 |
| [4] | LU Dahao, GAO Ju, HUANG Tianfeng, ZHANG Yang, WANG Xiaoying. Effect of electroacupuncture in alleviating central post-stroke pain in mice by inducing silent information regulator 1-dependent autophagy[J]. Journal of Clinical Medicine in Practice, 2022, 26(11): 42-47. DOI: 10.7619/jcmp.20220731 |
| [5] | XU Huafen, FENG Qiong, LI Chunlei. Expressions of matrix metalloproteinase-16, autophagy-related gene 5 and autophagy-related gene 7 in children with bronchial asthma and their correlations with pulmonary function[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 35-39. DOI: 10.7619/jcmp.20214839 |
| [6] | LI Yilong, LEI Kai, ZHANG Xiaozhao, DING Jingjian, ZHANG Shengtao, QIAO Wei, GUO Yongfeng. Study in effects of 1, 25-dihydroxyvitamin D3 on apoptosis and autophagy of colon cancer cells and its mechanism[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 5-9. DOI: 10.7619/jcmp.20211388 |
| [7] | BAI Jie, JI Wenjing, SHE Ling, Nuermaimaiti Yeerxun. Inhibitory effect of astaxanthin on autophagy and apoptosis of AGS cell infected by Helicobacter pylori[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 16-21, 29. DOI: 10.7619/jcmp.20201563 |
| [8] | YU Xin, MI Zhihua, GAO Ju. Role of autophagy in apoptosis of neurons in brain tissue of rats induced by mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2019, 23(8): 12-15, 21. DOI: 10.7619/jcmp.201908003 |
| [9] | WU Yingying, ZHANG Guoxing, LIU Di, TIAN Lili, ZHOU Guanhua, LIAO Wenqi, DAI Bin, CHEN Jingwei. Intervention of tiaozhi granules on autophagy of HUVECs[J]. Journal of Clinical Medicine in Practice, 2017, (5): 49-53. DOI: 10.7619/jcmp.201705014 |
| [10] | GU Zhijie, ZHANG Manhe, ZHOU Xiumin, XING Yanjie, ZHAO Xin, ZHANG Shuli. Effect of dexmedetomidine on hippocampal neuronal autophagy of rats with traumatic brain injury[J]. Journal of Clinical Medicine in Practice, 2016, (9): 14-16. DOI: 10.7619/jcmp.201609004 |
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: